Reticulocyte Hemoglobin as a Screening Test for Iron Deficiency Anemia: A New Cut-Off. 2023

Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
Internal Medicine Department, College of Medicine, Najran University, Najran 55461, Saudi Arabia.

BACKGROUND Latent iron deficiency (LID), in which iron stores in the body are depleted without incidental anemia, poses a key diagnostic challenge. Reticulocyte hemoglobin content (Ret-Hb) is directly correlated with the functionally available iron for heme synthesis in erythroblasts. Consequently, Ret-Hb has been proposed as an efficient iron status marker. OBJECTIVE To assess the importance of Ret-Hb in detecting latent iron deficiency as well as its use in screening for iron deficiency anemia. METHODS A study involving 108 individuals was conducted at Najran University Hospital, 64 of whom had iron deficiency anemia (IDA) and 44 of whom had normal hemoglobin levels. All patients were subjected to complete blood count (CBC), reticulocyte percentage, Ret-Hb, serum iron, total iron binding capacity (TIBC), and serum ferritin measurements. RESULTS A significant decrease in Ret-Hb level was observed in IDA patients compared to non-anemic individuals, with a cut-off value of 21.2 pg (a value below which indicates IDA). CONCLUSIONS The measurement of Ret-Hb, in addition to CBC parameters and indices, provides an accessible predictive marker for both iron deficiency (ID) and IDA. Lowering the Ret-Hb cut-off could better allow for its use as a screening parameter for IDA.

UI MeSH Term Description Entries

Related Publications

Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
January 2023, PloS one,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
August 2021, Journal of clinical medicine,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
July 2020, Biomedical and environmental sciences : BES,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
August 2005, JAMA,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
January 2004, Clinical laboratory,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
February 2024, Heliyon,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
January 2013, La Clinica terapeutica,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
July 2017, International journal of hematology,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
November 2016, The Journal of the Association of Physicians of India,
Abdullah I Aedh, and Mohamed S M Khalil, and Alaa S Abd-Elkader, and Mohamed M El-Khawanky, and Hamdan M Alshehri, and Amr Hussein, and Ali A Lafi Alghamdi, and Abdulkarim Hasan
September 2020, Laboratory medicine,
Copied contents to your clipboard!